Newcastle’s funding for translational research

The National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre (BRC) has now begun the next stage of its development, with the commencement of its latest £16m award from the Department of Health.

Based across the The Campus for Ageing and Vitality at Newcastle University, the Newcastle BRC is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University.

Originally established in 2012 through open competition, the Newcastle BRC brings together scientists and clinicians to accelerate the translation of novel scientific discoveries into improved treatments and clinical care in ageing syndromes and long-term conditions affecting the older person.

The NIHR Newcastle BRC is dedicated to experimental medicine and translational research in dementia, liver disease, musculoskeletal disease, neuromuscular disease and skin and oral disease. Since its original award, it has received two further rounds of five-year funding from the Department of Health through NIHR, with its latest award set to run until March 2022.

Following NIHR’s decision to discontinue the specialist Biomedical Research Units established in 2011, the work of the Newcastle Dementia Biomedical Research Unit will be continued and expanded upon in the NIHR Newcastle BRC as a theme dedicated to dementia and the ground-breaking work that the BRU has done in dementia with Lewy bodies.

NIHR manages research and development within the NHS, and the Newcastle BRC is one of 20 NIHR Biomedical Research Centres in England.  NIHR BRCs are tasked with:

  • Driving innovation in the prevention, diagnosis and treatment of ill-health.
  • Translating advances in biomedical research into benefits for patients.
  • Supporting the contribution of the NHS to the nation’s international competitiveness.

Our brand new site is undergoing some essential work and will be ready to view very soon. Until then, all current news and events can be found on this site, and you can also keep up to date with the latest on our Twitter feed.